Skip to content

Phadia

MedTech·Sweden·Exited 2011·Held 1yr
Entry
2010
Hold
1yr
Exit
2011

Who owns Phadia?

Phadia is a Swedish MedTech company, now owned by Thermo Fisher Scientific, which acquired it in 2011 from Cinven.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cinven
Most recent investor
Cinven
Cinven Fund IV · 2006 · Buyout
2 ownership periods · full history below

Key facts

HQSweden
SectorMedTech
Key takeaways
  • ·Fully exited in 2011 to Thermo Fisher Scientific Inc..
  • ·Average hold across 2 realized cycles: 2 years.

Ownership history

2 ownership periods

Exited
Last exited in 2011 to Thermo Fisher Scientific Inc..
Triton Partners
Triton PartnersExited 2007
2004 · 2007(3yr) · Triton Fund I · 2005 · Buyout
Secondary · to Cinven

Triton Partners sold Phadia to Cinven in 2007 after 3 years.

Cinven
CinvenExited 2011
2010 · 2011(1yr) · Cinven Fund IV · 2006 · Buyout
Trade Sale · to Thermo Fisher Scientific Inc.

Cinven sold Phadia to Thermo Fisher Scientific in 2011 after 1 year.

Questions

Who owns Phadia?

Phadia is now owned by Thermo Fisher Scientific, which acquired it in 2011 from Cinven.

When did Thermo Fisher Scientific acquire Phadia?

Thermo Fisher Scientific acquired Phadia in 2011, buying from Cinven.

Who did Phadia sell to?

Cinven sold Phadia to Thermo Fisher Scientific in 2011 (Trade Sale). Triton Partners sold Phadia to Cinven in 2007 (Secondary).

Who has owned Phadia over time?

Phadia has been through 2 private-equity ownership periods: Triton Partners · via Triton Fund I · 2004–2007 · sold to Cinven · (Secondary); Cinven · via Cinven Fund IV · 2010–2011 · sold to Thermo Fisher Scientific · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue